Stratum Biosciences provides SkinSync™, an AI‑driven platform that quantifies biological variation across skin regions and conditions to accelerate the discovery of novel active ingredients and optimize their formulation. By integrating large‑scale skin biology data with machine‑learning models, the platform predicts ingredient activity, skin‑penetration performance, and generates formulation designs for challenges such as aging, oxidative stress, and hyperpigmentation, reducing development time and cost for skincare manufacturers and dermatology product developers.
Funding
Funding not disclosed
Founders
Product
Problem
Skincare product development relies on lengthy, costly trial‑and‑error processes that often fail to deliver effective actives for complex skin issues such as aging, oxidative stress, and hyperpigmentation.
Solution
Stratum Biosciences offers SkinSync™, an AI‑driven platform that quantifies biological variation across skin regions and conditions. By integrating large‑scale skin biology data with machine‑learning models, the platform accelerates the discovery of novel active ingredients and optimizes their delivery through the skin barrier. The resulting insights enable rapid formulation design tailored to specific dermatological challenges, reducing development time and expense while improving efficacy.
Target Audience
Primary customers are skincare manufacturers, dermatology product developers, and biotech firms seeking accelerated, science‑based ingredient discovery and formulation.
Features
- AI engine that maps cellular and molecular skin characteristics across body sites and disease states
- Data‑driven prediction of ingredient activity and skin‑penetration performance
- Automated generation of candidate actives targeting aging, oxidative stress, and hyperpigmentation
- Integrated formulation optimization tools that align actives with barrier transport models
- Scalable platform architecture supporting high‑throughput screening of thousands of compounds